65597-407Level 3
Turalio (pexidartinib hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** PEXIDARTINIB HYDROCHLORIDE
**Strength:** 125 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Daiichi Sankyo Inc.
**Marketing category:** NDA (NDA211810)
**Pharmacologic class:** Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/65597-407Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.